Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Resmed Inc (RMD)

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,789,272
  • Shares Outstanding, K 144,668
  • Annual Sales, $ 2,607 M
  • Annual Income, $ 404,590 K
  • 60-Month Beta 0.50
  • Price/Sales 9.66
  • Price/Cash Flow 41.09
  • Price/Book 12.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.99
  • Number of Estimates 4
  • High Estimate 1.24
  • Low Estimate 0.75
  • Prior Year 0.95
  • Growth Rate Est. (year over year) +4.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.08 +22.29%
on 06/11/20
197.38 -2.68%
on 07/06/20
+25.59 (+15.37%)
since 06/10/20
3-Month
149.16 +28.78%
on 05/27/20
197.38 -2.68%
on 07/06/20
+32.27 (+20.19%)
since 04/09/20
52-Week
108.85 +76.47%
on 03/23/20
197.38 -2.68%
on 07/06/20
+68.09 (+54.91%)
since 07/10/19

Most Recent Stories

More News
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down

Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.

RMD : 192.09 (-0.83%)
PDCO : 23.09 (+1.56%)
WBA : 40.12 (+2.85%)
HEXO : 0.7500 (+1.99%)
Global Medical Ventilators Market

, /PRNewswire/ --This report examines the current and future market potential of medical ventilators. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement,...

GE : 6.69 (+1.67%)
MDT : 90.81 (+0.75%)
RMD : 192.09 (-0.83%)
Medical Products Industry's Near-Term Outlook Lacks Spark

Medical Products Industry's Near-Term Outlook Lacks Spark

ZBH : 119.43 (+1.52%)
SYK : 177.89 (+0.07%)
RMD : 192.09 (-0.83%)
PRGO : 55.17 (+1.68%)
MDT : 90.81 (+0.75%)
ISRG : 575.87 (+0.24%)
HRC : 110.95 (-0.13%)
BSX : 34.68 (+0.52%)
BAX : 85.23 (-0.54%)
ABT : 93.04 (-0.67%)
Here is Why Growth Investors Should Buy ResMed (RMD) Now

ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.

RMD : 192.09 (-0.83%)
Sustainable Investment Forms Part of the New Normal: 5 Picks

ESG policies and practices yielded positive outcomes during the coronavirus slump. Also, millennials-driven sustainable investing trend will continue post-pandemic.

RMD : 192.09 (-0.83%)
NEE : 259.60 (+3.02%)
PG : 123.89 (+1.15%)
WST : 232.23 (-1.57%)
MKC : 185.91 (+1.12%)
GLOBAL SMART INHALERS MARKET FORECAST 2019-2028

, /PRNewswire/ -- The global smart inhalers market is projected to garner considerable revenue, growing at a CAGR of 31.66%, during the forecast period of 2019 to 2028. The drivers facilitating the market...

A : 89.42 (-0.56%)
AZN : 53.76 (-0.39%)
GSK : 39.91 (-1.14%)
NVS : 87.01 (-0.38%)
OPK : 4.02 (unch)
RMD : 192.09 (-0.83%)
TEVA : 11.76 (+1.29%)
VEGPF : 1.2237 (+53.92%)
Remote Patient Monitoring Gains Prominence: 3 Stocks to Watch

Let's keep a watch on three stocks that are committed toward enhancing and offering RPM to fight against coronavirus.

MDT : 90.81 (+0.75%)
MDRX : 6.60 (+2.64%)
MASI : 231.13 (-2.26%)
RMD : 192.09 (-0.83%)
Here's Why You Should Hold on to ResMed (RMD) Stock for Now

Investors continue to be upbeat about ResMed (RMD) owing to its strong emphasis on product development and consistent high demand for its critical care products.

DGX : 116.82 (+0.84%)
HOLX : 57.69 (+0.39%)
RMD : 192.09 (-0.83%)
QGEN : 45.31 (+1.71%)
Sommetrics Requests Emergency Use Authorization to Introduce Its aerSleep Product for Sleep Apnea Patients at Risk of COVID-19

Sommetrics, Inc., a company providing products and services to improve sleep quality, announced it filed an application with the FDA for Emergency Use Authorization to introduce its aerSleep(R) II product...

PHG : 47.23 (-0.30%)
RMD : 192.09 (-0.83%)
SmarTrend Watching for Potential Pullback in Shares of Resmed Inc After 3.36% Gain

Resmed Inc (NYSE:RMD) traded in a range yesterday that spanned from a low of $174.26 to a high of $178.89. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $177.00...

RMD : 192.09 (-0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade RMD with:

Business Summary

ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions....

See More

Key Turning Points

2nd Resistance Point 197.29
1st Resistance Point 194.69
Last Price 192.09
1st Support Level 190.16
2nd Support Level 188.23

See More

52-Week High 197.38
Last Price 192.09
Fibonacci 61.8% 163.56
Fibonacci 50% 153.12
Fibonacci 38.2% 142.67
52-Week Low 108.85

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar